DOI QR코드

DOI QR Code

Specific Detection of Acanthamoeba species using Polyclonal Peptide Antibody Targeting the Periplasmic Binding Protein of A. castellanii

  • Kim, Min-Jeong (Department of Biomedical Science, Graduate School, Kyung Hee University) ;
  • Quan, Fu-Shi (Department of Medical Zoology, Kyung Hee University School of Medicine) ;
  • Kong, Hyun-Hee (Department of Parasitology, Dong-A University College of Medicine) ;
  • Kim, Jong-Hyun (Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University) ;
  • Moon, Eun-Kyung (Department of Medical Zoology, Kyung Hee University School of Medicine)
  • Received : 2021.12.26
  • Accepted : 2022.04.01
  • Published : 2022.04.30

Abstract

Acanthamoeba keratitis (AK) is a rare ocular disease, but it is a painful and sight-threatening infectious disease. Early diagnosis and adequate treatment are necessary to prevent serious complications. While AK is frequently diagnosis via several PCR assays or Acanthamoeba-specific antibodies, a more specific and effective diagnostic method is required. This study described the production of a polyclonal peptide antibody against the periplasmic binding protein (PBP) of A. castellanii and investigated its diagnostic potential. Western blot analysis showed that the PBP antibody specifically reacted with the cell lysates of A. castellanii. However, the PBP antibody did not interact with human corneal epithelial (HCE) cells and the other 3 major causative agents of keratitis. Immunocytochemistry (ICC) results revealed the specific detection of A. castellanii trophozoites and cysts by PBP antibodies when A. castellanii were co-cultured with HCE cells. PBP antibody specificity was further confirmed by co-culture of A. castellanii trophozoites with F. solani, S. aureus, and P. aeruginosa via ICC. The PBP antibody specifically reacted with the trophozoites and cysts of A. polyphaga, A. hatchetti, A. culbertsoni, A. royreba, and A. healyi, thus demonstrated its genus-specific nature. These results showed that the PBP polyclonal peptide antibody of A. castellanii could specifically detect several species of Acanthamoeba, contributing to the development of an effective antibody-based AK diagnostics.

Keywords

Acknowledgement

This work was supported by the National Research Foundation of Korea (NRF) grant funded by Korea government (MIST) (No. 2020R1A2C1005345).

References

  1. Marciano-Cabral F, Cabral G. Acanthamoeba spp. as agents of disease in humans. Clin Microbiol Rev 2003; 16: 273-307. https://doi.org/10.1128/CMR.16.2.273-307.2003
  2. Schuster FL, Visvesvara GS. Free-living amoebae as opportunistic and non-opportunistic pathogens of humans and animals. Int J Parasitol 2004; 34: 1001-1027. https://doi.org/10.1016/j.ijpara.2004.06.004
  3. Page MA, Mathers WD. Acanthamoeba keratitis: a 12-year experience covering a wide spectrum of presentations, diagnoses, and outcomes. J Ophthalmol 2013; 2013: 670242. https://doi.org/10.1155/2013/670242
  4. Fanselow N, Sirajuddin N, Yin XT, Huang AJW, Stuart PM. Acanthamoeba keratitis, pathology, diagnosis and treatment. Pathogens 2021; 10: 323. https://doi.org/10.3390/pathogens10030323
  5. Yera H, Ok V, Lee Koy Kuet F, Dahane N, Ariey F, Hasseine L, Delaunay P, Martiano D, Marty P, Bourges JL. PCR and culture for diagnosis of Acanthamoeba keratitis. Br J Ophthalmol 2021; 105: 1302-1306. http://dx.doi.org/10.1136/bjophthalmol-2020-316730
  6. Rasheed AK, Siddiqui R, Ahmed SMK, Gabriel S, Jalal MZ, John A, Khan NA. hBN nanoparticle-assisted rapid thermal cycling for the detection of Acanthamoeba. Pathogens 2020; 9: 824. https://doi.org/10.3390/pathogens9100824
  7. Maubon D, Dubosson M, Chiquet C, Yera H, Brenier-Pinchart MP, Cornet M, Savy O, Renard E, Pelloux H. A one-step multiplex PCR for acanthamoeba keratitis diagnosis and quality samples control. Invest Ophthalmol Vis Sci 2012; 53: 2866-2872. https://doi.org/10.1167/iovs.11-8587
  8. Laummaunwai P, Ruangjirachuporn W, Boonmars T. A simple PCR condition for detection of a single cyst of Acanthamoeba species. Parasitol Res 2012; 110: 1569-1572. doi: 10.1007/s00436-011-2662-3
  9. Turner ML, Cockerell EJ, Brereton HM, Badenoch PR, Tea M, Coster DJ, Williams KA. Antigens of selected Acanthamoeba species detected with monoclonal antibodies. Int J Parasitol 2005; 35: 981-990. https://doi.org/10.1016/j.ijpara.2005.03.015
  10. Weber-Lima MM, Prado-Costa B, Becker-Finco A, Costa AO, Billilad P, Furst C, de Moura JF, Alvarenga LM. Acanthamoeba spp. monoclonal antibody against a CPA2 transporter: a promising molecular tool for acanthamoebiasis diagnosis and encystment study. Parasitology 2020; 147: 1678-1688. https://doi.org/10.1017/S0031182020001778
  11. Kang AY, Park AY, Shin HJ, Khan NA, Maciver SK, Jung SY. Production of a monoclonal antibody against a mannose-binding protein of Acanthamoeba culbertsoni and its localization. Exp Parasitol 2018; 192: 19-24. https://doi.org/10.1016/j.exppara.2018.07.009
  12. Park SM, Lee HA, Chu KB, Quan FS, Kim SJ, Moon EK. Production of a polyclonal antibody against inosine-uridine preferring nucleoside hydrolase of Acanthamoeba castellanii and its access to diagnosis of Acanthamoeba keratitis. PLoS One 2020; 15: e0239867. https://doi.org/10.1371/journal.pone.0239867
  13. Lee HA, Chu KB, Kim MJ, Quan FS, Kong HH, Moon EK. Chorismate mutase peptide antibody enables specific detection of Acanthamoeba. PLoS One 2021; 16: e0250342. https://doi.org/10.1371/journal.pone.0250342
  14. Singh A, Sahu SK, Sharma S, Das S. Acanthamoeba keratitis versus mixed acanthamoeba and bacterial keratitis: comparison of clinical and microbiological profiles. Cornea 2020; 39: 1112-1116. https://doi.org/10.1097/ICO.0000000000002337
  15. Raghavan A, Baidwal S, Venkatapathy N, Rammohan R. The Acanthamoeba-fungal keratitis study. Am J Ophthalmol 2019; 201: 31-36. https://doi.org/10.1016/j.ajo.2019.01.024
  16. Moon EK, Choi HS, Park SM, Kong HH, Quan FS. Comparison of proteins secreted into extracellular space of pathogenic and non-pathogenic Acanthamoeba castellanii. Korean J Parasitol 2018; 56: 553-558. https://doi.org/10.3347/kjp.2018.56.6.553
  17. Ko W, Kim S, Lee HS. Engineering a periplasmic binding protein for amino acid sensors with improved binding properties. Org Biomol Chem 2017; 15: 8761-8769. https://doi.org/10.1039/C7OB02165H
  18. Edwards KA, Baeumner AJ. Periplasmic binding protein-based detection of maltose using liposomes: a new class of biorecognition elements in competitive assays. Anal Chem 2013; 85: 2770-2778. https://doi.org/10.1021/ac303258n
  19. Edwards KA, Randall EA, Tu-Maung N, Sannino DR, Feder S, Angert ER, Kraft CE. Periplasmic binding protein-based magnetic isolation and detection of thiamine in complex biological matrices. Talanta 2019; 205: 120168. https://doi.org/10.1016/j.talanta.2019.120168
  20. Baek M, DiMaio F, Anishchenko I, Dauparas J, Ovchinnikov S, Lee GR, Wang J, Cong Q, Kinch LN, Schaeffer RD, Millan C, Park H, Adams C, Glassman CR, DeGiovanni A, Pereira JH, Rodrigues AV, van Dijk AA, Ebrecht AC, Opperman DJ, Sagmeister T, Buhlheller C, Pavkov-Keller T, Rathinaswamy MK, Dalwadi U, Yip CK, Burke JE, Garcia KC, Grishin NV, Adams PD, Read RJ, Baker D. Accurate prediction of protein structures and interactions using a three-track neural network. Science 2021; 373: 871-876. https://doi.org/10.1126/science.abj8754
  21. Maycock NJ, Jayaswal R. Update on Acanthamoeba keratitis: diagnosis, treatment, and outcomes. Cornea 2016; 35: 713-720. https://doi.org/10.1097/ICO.0000000000000804
  22. Moon EK, Xuan YH, Kong HH. Microarray and KOG analysis of Acanthamoeba healyi genes up-regulated by mouse-brain passage. Exp Parasitol 2014; 143: 69-73. https://doi.org/10.1016/j.exppara.2014.05.012